Categories Analysis, Consumer, Earnings

Earnings preview: Herman Miller to benefit from growing demand in Q3

The market is quite upbeat about the third-quarter financial performance of Herman Miller (MLHR), which is slated to announce the results Wednesday after the closing bell. This time, analysts will be looking for a bigger earnings growth than in the previous quarters, and the consensus estimate indicates a 22% year-on-year increase to $0.61 per share.

Considering the positive surprises in the trailing four quarters, an earnings beat is very much in the cards. Revenues are forecast to move up 8% to $623.35 million. The furniture manufacturer continues to benefit from the recent spurt in the demand for residential and office furniture.

Considering the positive surprises in the trailing four quarters, an earnings beat is very much in the cards

Analysts have given the company’s stock a buy rating, with a price target of $40. Being on a recovery path, with a price that is still below the long-term average, the stock is an investment option worth considering. Also, lower debt and a reasonably good return on equity make it appealing.

Also see: Herman Miller Q2 2019 Earnings Conference Call Transcript

Meanwhile, it needs to be seen as to what extent the management will be able to take forward the expansion activities without external funding. Also, the deceleration in earnings growth over the years could be a dampener as far as investor sentiment is concerned.  Last year, Herman Miller’s profit gained at a pace that is slower than its five-year average growth rate, indicating that the slowdown might continue in the coming quarters.

For the second quarter, the Zeeland, Michigan-based company reported record sales of $653 million, up 8%, supported by a 10% organic order growth. Consequently, adjusted earnings surged 32% annually to $0.75 per share.

Herman Miller shares have maintained a steady uptrend after slipping to an eight-month low towards the end of last year. The stock gained about 18% since the beginning of the year and moved up 17% in the past twelve months.

 

Listen to on-demand earnings calls and hear how management responds to analysts’ questions

Most Popular

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Walgreens Boots Alliance set to report earnings next week. Here’s what to expect

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the drug store chain that is expanding into a diversified healthcare provider, is on a restructuring drive aimed at better aligning the business with

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top